Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anixa Biosciences Inc ANIX

Healthcare Biotechnology
Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs include the development of a preventative vaccine against triple negative breast cancer (TNBC), the most lethal form of breast cancer, as well... see more

Recent & Breaking News (NDAQ:ANIX)

Anixa Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference

PR Newswire January 5, 2021

Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine

PR Newswire December 21, 2020

Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency to Remdesivir in Pre-Clinical Testing

PR Newswire December 14, 2020

Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology

PR Newswire December 1, 2020

Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine

PR Newswire November 23, 2020

Anixa Biosciences to Host Conference Call to Provide Update on Programs

PR Newswire October 27, 2020

Anixa Biosciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference

PR Newswire September 8, 2020

Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds

PR Newswire August 13, 2020

Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission

PR Newswire July 28, 2020

Anixa Biosciences Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders

PR Newswire July 20, 2020

Anixa Biosciences' CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent Office

PR Newswire July 10, 2020

Anixa and OntoChem Announce Completion of Initial Screening Program and Identification of Additional Covid-19 Compounds

PR Newswire July 6, 2020

Anixa Announces Strategic Program Realignment Focused on Advancement of its Therapeutic and Vaccine Pipeline

PR Newswire July 2, 2020

Anixa Biosciences and OntoChem Have Synthesized Four Potential Covid-19 Drugs for Testing in Biological Assays

PR Newswire June 1, 2020

Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate

PR Newswire May 4, 2020

Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Biomarker Insights Highlighting Cchek(TM) Liquid Biopsy Technology

PR Newswire April 23, 2020

Anixa Biosciences and OntoChem Announce Collaboration to Develop Novel COVID-19 Therapeutics

PR Newswire April 20, 2020

Anixa Biosciences Announces Presentation at AI and Big Data in Cancer Conference

PR Newswire March 2, 2020

Anixa Biosciences and Moffitt Cancer Center Announce Completion of Viral Vector Reformulation for CAR-T Program

PR Newswire February 12, 2020

Anixa Biosciences Announces Presentation at AACR Liquid Biopsies Conference

PR Newswire January 6, 2020